Zeb2cDC2

Tian-Tian Liu1, Sunkyung Kim1, Pritesh Desai2

  • 1Department of Pathology and Immunology, Washington University in St Louis, School of Medicine, St Louis, MO, USA.

Nature
|June 22, 2022
PubMed
概括

该研究显示,转录因子NFIL3和C/EBP在Zeb2增强剂中竞争,以控制树突细胞原始细胞的分离. 这种竞争对于确定2型树突细胞 (cDC2) 和它们在T辅助细胞反应中的作用至关重要.